Results and discussion
Using an oligonucleotide encoding the conserved WSXWS (single-letter amino acid code) motif present in the extracellular domains of hemopoietin receptors [2] , a cDNA denoted NR6 was isolated from murine testis, brain and KUSA cell line [5] cDNA libraries. The majority of clones contained a long open-reading frame (NR6.1) of 1275 nucleotides. The predicted protein sequence was consistent with that of a haemopoietin receptor [2] : a potential signal sequence and immunoglobulin-like domain preceded a haemopoietin domain (HD) containing the expected cysteine pairs and a WSEWS motif, and sequence with loose homology to part of the fibronectin type III repeat was evident at the carboxyl terminus. Independent clones were also isolated with deduced open reading frames (NR6.2 and NR6.3) that contained divergent sequences carboxy-terminal to the HD ( Figure 1 ). Human NR6 cDNAs, all of which were homologues of murine NR6.1, were isolated using low-stringency hybridisation of murine probes to foetal kidney, foetal liver and placental libraries ( Figure 1 ). No hydrophobic sequences typical of a transmembrane domain nor motifs usually required for membrane association via lipid attachment [6] were evident, indicating that NR6 is a soluble member of the haemopoietin receptor family. The primary amino-acid sequences of human and mouse NR6.1 were 98% identical and are identical to the recently described cytokine-like factor-1 (CLF-1) [7] . Although NR6 has sequence similarity to membrane-bound haemopoietin receptors (Figure 1) , structurally it appears to be analogous to the two other exclusively soluble members of the haemopoietin receptor family -EBI3, a 34 kDa glycoprotein secreted by B lymphocytes in response to EBV [4] , and the p40 component of IL-12 [3] .
Embryos at 7.5-11.5 days post coitum (dpc) were examined for NR6 expression by whole-mount in situ hybridisation with digoxigenin-labelled riboprobes. NR6 expression was first detected at 9.5 dpc in the first branchial arch, the forelimb bud and mesonephric duct (Figure 2a ). At 10.5 and 11.5 dpc, intense expression was seen in nasal processes and the maxillary and mandibular components of the first branchial arch. Expression was also seen in the limbs, in the mesenchyme overlying the otic vesicle and in the dermatomyotome (Figure 2b ). Expression of NR6 in 12.5, 14.5 and 18.5 dpc embryos was examined by in situ hybridisation of radiolabelled probes to tissue sections. At each age, NR6 was expressed in the craniofacial mesenchyme and in tissues derived from the first branchial arch. At 14.5 and 18.5 dpc, NR6 transcripts were also observed in dental papillae, in the tongue and throughout the mesenchyme beneath the oral and nasal epithelia (Figure 2e ). Expression was observed in the secretory buds and ducts of the submandibular salivary gland from 14.5 dpc and in the lacrimal glands at 18.5 dpc (Figure 2e ). At 12.5 and 14.5 dpc the ectoderm of Rathke's pouch expressed NR6, although transcripts were not detected in the pituitary gland. NR6 was expressed in the mesonephric (Wolffian) duct at 12.5 dpc and in the growing tips of the collecting ducts of the kidney throughout embryogenesis (Figure 2c ). Expression was observed in the genital tubercle but was not detected in other reproductive organs (Figure 2c ). NR6 transcripts were detected in the lung buds at 12.5 dpc and in the bronchi, but not in lung parenchyma, at 14.5 and 18.5 dpc (Figure 2c ). From 12.5 dpc, NR6 expression was observed in all precartilaginous membranous blastema. At later times, expression was prominent in tissues adjacent to forming cartilage, such as the intermediate digits of the hindlimb (Figure 2c ). NR6 transcripts were not detected in the developing brain before 17.5 dpc. At this time, expression was observed in the nuclear zone of the neopallial cortex and in the hippocampus (Figure 2c ). Rare NR6-positive cells were also observed in the midbrain. By birth, expression of NR6 in the brain was no longer detectable.
To examine the biological role of NR6 in vivo, a targeting vector in which the NR6 immunoglobulin-like and haemopoietin domains were replaced with a G418-resistance cassette (Figure 3a ) was used for homologous recombination in embryonic stem (ES) cells to generate mice in which the NR6 gene had been functionally deleted. A number of mice in litters born of NR6 +/-parents died within 24 hours of birth. Genotyping revealed that these mice were homozygous for the targeted NR6 allele, whereas their healthy littermates were heterozygotes or wild type ( Figure 3b ). As anticipated, NR6 transcripts were detected in northern blot analysis of RNA from NR6 +/-or wild-type mice, but were absent in samples from homozygous mutants (Figure 3c ). Although NR6 -/-mice were born in numbers expected from normal Mendelian segregation of alleles, no NR6 -/-mice survived beyond 24 hours after birth. Thus loss of NR6 does not compromise embryonic survival but is lethal during the first day of life.
Extensive histological comparison of serial sections from neonatal NR6 -/-mice and wild-type littermates revealed Expression of NR6 in the mouse embryo. (a,b) Whole-mount in situ hybridisation of (a) 9.5 dpc and (b) 11.5 dpc embryos showing NR6 expression in the mesonephric duct (md), limb buds (lb), first branchial arch (ba1), nasal processes and dermatomyotome (dm). (c) Sagittal section of a 14.5 dpc embryo showing NR6 expression in lung (l), kidney (k), genital tubercle (gt), precartilaginous condensations of the digital metacarpals (d), intervertebral discs (id), tongue (t) and facial mesenchyme. (d,e) Serial sagittal sections of the head from an 18.5 dpc embryo, hybridised with (d) sense and (e) antisense probes revealing NR6 expression in the cortex (c) and hippocampus (hi), as well as in facial mesenchyme, developing teeth (th) and salivary gland (sg). Scale bars, 1 mm. Hybridisation of a 33 P-labelled full-length NR6 cDNA probe to whole-mount (70°C) and embryonic paraffin sections (50°C) were performed as described previously [12, 13] . 
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NR6 is a member of the haemopoietin receptor family. Alignment of the amino-acid sequence of murine (mNR6) and human (hNR6) NR6 with those of human Epstein-Barr virus-induced protein (hEBI3), the p40 component of human IL-12 (hIL-12p40), and the human receptors for IL-6 (hIL-6Rα), ciliary neurotrophic factor (hCNTFRα) and granulocytemacrophage colony-stimulating factor (hGMRα). Conserved residues in the SD100A (grey) and SD100B (blue) regions of the haemopoietin domain are shaded, with the characteristic cysteine pairs and WSXWS motifs in bold. The carboxy-terminal sequences that diverge in mNR6.1, mNR6.2 and mNR6.3 are shown in pink together with the hNR6 carboxyl terminus.
no gross structural abnormalities or histopathology. Specific staining of bone and cartilage in cleared embryos [8] collected the day before birth also failed to detect any consistent skeletal abnormalities (data not shown). Closer examination soon after birth revealed that NR6 -/-mice failed to suckle effectively and had stomachs devoid of milk ( Figure 4) . The NR6 -/-mice had normal body weights, a normal respiratory rate, were well oxygenated and responded to touch with vocalisation, righting and rooting reflexes. They could open and close their mouths and dissections revealed that the palate, mouth and oesophagus were intact. Suckling is thought to be initiated by pheromonal responses which are processed by neural networks involving the olfactory bulb, and ultimately, the hippocampus [9] . Indeed, in mice lacking the Fyn tyrosine kinase, a failure to suckle has been correlated with abnormalities at these sites [10] . In contrast, in mice lacking the Brn-3a POU domain protein, neuronal loss in the trigeminal ganglion accompanied a failure to suckle, suggesting that sensory defects in the face or mouth may also impair this response [11] . The brains of two newborn NR6 -/-mice and two wild-type littermates were serially sectioned in the coronal plane and every fifth section was photographed. Sagittal sections through the brain, face and mouth of several animals were also examined. No abnormalities were observed in the anatomy of the NR6 -/-brains, including the cortex and hippocampus, the two sites of NR6 expression, and the olfactory bulb. The complete brain stem was not examined. Similarly, gross structural or histological abnormalities of the face and mouth were not evident. Thus, although our data establish that NR6 is indispensable in the initiation and/or maintenance of suckling in neonatal mice, and reveal NR6 expression in facial and neural sites previously implicated in suckling, we have not been able to identify the mechanism by which its role is mediated. It seems likely, however, that the expression of NR6 in facial tissues and/or the brain is necessary for the recognition or processing of pheromonal signals or for the mechanics of suckling itself.
We also examined whether haemopoiesis was perturbed in NR6 -/-mice. The haematocrit number of circulating platelets and number and morphological distribution of white blood cells were normal in NR6 -/-mice. The numbers and lineage commitment of haemopoietic progenitor cells in neonatal mice were enumerated in clonogenic cultures. NR6 -/-bone marrow and spleen contained 1.5-2.5-fold fewer progenitors capable of responding to the combination of stem-cell factor (SCF), IL-3 and erythropoietin (EPO). A similar reduction in the number of clonogenic cells responsive to macrophage colony-stimulating factor (M-CSF) or SCF alone was also observed (data not shown). The deficiencies did not reflect a reduction in cells
Brief Communication 607 committed to any particular lineage; fewer colonies of all types monitored were evident ( Table 1) . The numbers and lineage commitment of haemopoietic progenitor cells were normal in the livers of neonatal NR6 -/-mice (Table 1) , and in similar analyses, no disturbances in foetal liver progenitor numbers or lineage commitment were evident at day 13 of gestation (data not shown). Although it is possible that the debilitating effects of the failure to suckle in these mice causes marrow and spleen progenitor cell numbers to quickly decrease after birth, the intact response of liver progenitors from the same animals suggests that this is not the case. Rather, NR6 may be required for progenitor cell production in spleen and bone marrow late in gestation. In support of a potential role as a haemopoietic regulator, NR6 is expressed by a number of stromal cell lines known to support haemopoiesis (data not shown).
Thus, NR6 is indispensable for suckling, with lethal consequences in neonatal mice lacking this protein. It is also required for appropriate production of haemopoietic progenitor cells in the bone marrow and spleen. Further studies are required to define this soluble haemopoietin receptor biochemically and to further explore its contributions to these complex biological processes.
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